Regenxbio Inc (RGNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 6,393 | 30,337 | 29,733 | 21,359 | 89,012 |
| Cost of Goods | 11,074 | 5,928 | 5,725 | 5,209 | 3,436 |
| Gross Profit | -4,681 | 24,409 | 24,008 | 16,150 | 85,576 |
| Operating Expenses | 78,755 | 82,973 | 77,144 | 79,637 | 73,885 |
| Operating Income | -83,362 | -57,636 | -52,411 | -63,278 | 12,127 |
| Interest Expense | 8,708 | 12,276 | 13,169 | 10,993 | 8,570 |
| Other Income | 2,019 | 2,763 | 3,639 | 3,400 | 2,526 |
| Pre-tax Income | -90,051 | -67,149 | -61,941 | -70,871 | 6,083 |
| Net Income Continuous | -90,051 | -67,149 | -61,941 | -70,871 | 6,083 |
| Net Income | $-90,051 | $-67,149 | $-61,941 | $-70,871 | $6,083 |
| EPS Basic Total Ops | -1.72 | -1.30 | -1.20 | -1.38 | 0.12 |
| EPS Basic Continuous Ops | -1.72 | -1.30 | -1.20 | -1.38 | 0.12 |
| EPS Diluted Total Ops | -1.72 | -1.30 | -1.20 | -1.38 | 0.12 |
| EPS Diluted Continuous Ops | -1.72 | -1.30 | -1.20 | -1.38 | 0.12 |
| EPS Diluted Before Non-Recurring Items | -1.72 | -1.30 | -1.20 | -1.38 | 0.12 |
| EBITDA(a) | $-80,384 | $-53,767 | $-46,098 | $-60,729 | $15,011 |